Search

everythinglearnresearchcommunity

for

Search:↓

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Targeting lipid metabolism can help treat advanced, resistant cancers.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

Trastuzumab deruxtecan is effective for advanced breast cancer but has side effects like nausea and fatigue.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

A man's rare adrenal tumor caused feminization and white hair, was removed surgically, and improved after treatment.

Radiotherapy affects mitochondrial-related genes in metastatic breast cancer cells.

Hair loss can occur as a side effect of certain breast cancer treatments, but minoxidil can help regrow hair.

Lack of certain cells causes abnormal nipple development and nursing failure.

Rapamycin and anti-EGFR antibody reduce LAM/TSC cell migration and blood vessel growth in the uterus.

The new nanoparticles could improve melanoma treatment by working better than current options.

Certain genes can predict how well breast cancer patients respond to chemotherapy.

Cialis and Finasteride could be repurposed to treat aggressive melanoma.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Combining L-cysteine, NAC, and a MET inhibitor significantly kills cervical cancer cells.

Tadalafil and Finasteride may help treat aggressive melanoma.

Vaccines and targeting TrxR variants can help prevent cancer and reduce metastasis.

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

Stem cells slowed lung tumor growth but increased colon tumor growth in mice.

Some breast cancer patients treated with high-dose docetaxel may experience permanent hair loss.

Finasteride use may increase the risk of male breast cancer.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Surgery may be needed for resistant thyrotoxicosis.

Sex hormones might influence bladder cancer development, and aromatase inhibitors could increase risk in postmenopausal women.